絞り込み

17875

広告

「"Leyvraz S "[Author]」の検索結果

183件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Challenges in the Diagnosis of NTRK Fusion-Positive Cancers.

Support of a molecular tumour board by an evidence-based decision management system for precision oncology.

Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways Inhibition.

Meta-Analysis in Metastatic Uveal Melanoma to Determine Progression-Free and Overall Survival Benchmarks: an International Rare Cancers Initiative (IRCI) Ocular Melanoma study.

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

[Conjunctival melanoma : Standard operating procedures in diagnosis, treatment and follow-up care].

Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).

Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.

Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.

Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group.

UV light signature in conjunctival melanoma; not only skin should be protected from solar radiation.

Radiotherapy for GIST progressing during or after tyrosine kinase inhibitor therapy: A prospective study.

Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.

Health-related quality of life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.

Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative.

High Expression of hTERT and Stemness Genes in BORIS/CTCFL Positive Cells Isolated from Embryonic Cancer Cells.

Adjuvant Radiotherapy for extremity and trunk wall Atypical Lipomatous Tumor/Well-Differentiated LPS (ALT/WD-LPS): A French Sarcoma Group (GSF-GETO) study.

Long-Term Remission of an Aggressive Sebaceous Carcinoma following Chemotherapy.

MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
Sort by
※並べ替えは表示に時間がかかります